Despite the critical role of SMAD4 in tumor suppression, the molecular mechanisms linking SMAD4 loss to oncogenesis remain poorly understood and cannot be solely attributed to disruptions in canonical TGF-β signaling. The gene discussed is TGFB1; the disease is neoplasm.